Yoko Nakajima

Dr. Yoko Nakajima


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2014 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Open access
PDF file
YNYoko Nakajima
Yoko Nakajima
JMJudith Meijer
Judith Meijer
DDDoreen Dobritzsch
Doreen Dobritzsch
TITetsuya Ito
Tetsuya Ito
RMRutger Meinsma
Rutger Meinsma
AKAndré B. P. van Kuilenburg
André B. P. van Kuilenburg
β‐ureidopropionase (βUP) deficiency is an autosomal recessive disease characterized by N‐carbamyl‐β‐amino aciduria. To date, only 16 genetically confirmed patients with βUP deficiency have been reported. Here, we report on the clinical, biochemical and molecular findings of 13 Japanese βUP deficient patients. In this group of patients, three novel missense mutations (p.G31S, p.E271K, and p.I286T) and a recently described mutation (p.R326Q) were identified. The p.R326Q mutation was detected in all 13 patients with eight patients being homozygous for this mutation. Screening for the p.R326Q mutation in 110 Japanese individuals showed an allele frequency of 0.9 %. Transient expression of mutant βUP enzymes in HEK293 cells showed that the p.E271K and p.R326Q mutations cause profound decreases in activity (≤ 1.3 %). Conversely, βUP enzymes containing the p.G31S and p.I286T mutations possess residual activities of 50 and 70 %, respectively, suggesting we cannot exclude the presence of additional mutations in the non‐coding region of theUPB1gene. Analysis of a human βUP homology model revealed that the effects of the mutations (p.G31S, p.E271K, and p.R326Q) on enzyme activity are most likely linked to improper oligomer assembly. Highly variable phenotypes ranging from neurological involvement (including convulsions and autism) to asymptomatic, were observed in diagnosed patients. High prevalence of p.R326Q in the normal Japanese population indicates that βUP deficiency is not as rare as generally considered and screening for βUP deficiency should be included in diagnosis of patients with unexplained neurological abnormalities.

1 November 2011 in Brain and Development
Verified
Journal Article
Closed access
YNYoko Nakajima
Yoko Nakajima
TITetsuya Ito
Tetsuya Ito
YMYasuhiro Maeda
Yasuhiro Maeda
SISayaka Ichiki
Sayaka Ichiki
SKSatoru Kobayashi
Satoru Kobayashi
HTHajime Togari
Hajime Togari

1 December 2017 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
YNYoko Nakajima
Yoko Nakajima
JMJudith Meijer
Judith Meijer
DDDoreen Dobritzsch
Doreen Dobritzsch
TITetsuya Ito
Tetsuya Ito
CZChunhua Zhang
Chunhua Zhang
AKAndré B.P. van Kuilenburg
André B.P. van Kuilenburg

Verified
Journal Article
Open access
PDF file
YNYoko Nakajima
Yoko Nakajima
JMJudith Meijer
Judith Meijer
CZChunhua Zhang
Chunhua Zhang
XWXu Wang
Xu Wang
TKTomomi Kondo
Tomomi Kondo
AKAndré B. P. Van Kuilenburg
André B. P. Van Kuilenburg
Dihydropyrimidinase (DHP) deficiency is an autosomal recessive disease caused by mutations in the DPYS gene. Patients present with highly elevated levels of dihydrouracil and dihydrothymine in their urine, blood and cerebrospinal fluid. The analysis of the effect of mutations in DPYS on pre-mRNA splicing is hampered by the fact that DHP is primarily expressed in liver and kidney cells. The minigene approach can detect mRNA splicing aberrations using cells that do not express the endogenous mRNA. We have used a minigene-based approach to analyze the effects of a presumptive pre-mRNA splicing mutation in two newly identified Chinese pediatric patients with DHP deficiency. Mutation analysis of DPYS showed that both patients were compound heterozygous for a novel intronic mutation c.1443+5G>A in intron 8 and a previously described missense mutation c.1001A>G (p.Q334R) in exon 6. Wild-type and the mutated minigene constructs, containing exons 7, 8 and 9 of DPYS, yielded different splicing products after expression in HEK293 cells. The c.1443+5G>A mutation resulted in altered pre-mRNA splicing of the DPYS minigene construct with full skipping of exon 8. Analysis of the DHP crystal structure showed that the deletion of exon 8 severely affects folding, stability and homooligomerization of the enzyme as well as disruption of the catalytic site. Thus, the analysis suggests that the c.1443+5G>A mutation results in aberrant splicing of the pre-mRNA encoding DHP, underlying the DHP deficiency in two unrelated Chinese patients.

12 December 2018 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
KYKatsuyuki Yokoi
Katsuyuki Yokoi
YNYoko Nakajima
Yoko Nakajima
HIHidehito Inagaki
Hidehito Inagaki
MTMakiko Tsutsumi
Makiko Tsutsumi
TITetsuya Ito
Tetsuya Ito
Hiroki KurahashiHiroki Kurahashi
Hiroki Kurahashi
Ornithine transcarbamylase deficiency (OTCD) is an X-linked recessive disorder involving a defect in the urea cycle caused by OTC gene mutations. Although a total of 417 disease-causing mutations in OTC have been reported, structural abnormalities in this gene are rare. We here describe a female OTCD case caused by an exonic duplication of the OTC gene (exons 1–6). A 23-year-old woman with late-onset OTCD diagnosed by biochemical testing was subjected to subsequent genetic testing. Sanger sequencing revealed no pathogenic mutation throughout the coding exons of the OTC gene, but multiplex ligation-dependent probe amplification (MLPA) revealed duplication of exons 1–6. Further genetic analyses revealed an inversion of duplicated exon 1 and a tandem duplication of exons 2–6. Each of the junctions of the inversion harbored a microhomology and non-templated microinsertion, respectively, suggesting a replication-based mechanism. The duplication was also of de novo origin but segregation analysis indicated that it took place in the paternal chromosome. We report the first OTCD case harboring an exonic duplication in the OTC gene. The functional defects caused by this anomaly were determined via structural analysis of its complex rearrangements.

1 March 2017 in Journal of Chromatography B
Verified
Journal Article
Closed access
KGKana Gotoh
Kana Gotoh
YNYoko Nakajima
Yoko Nakajima
GTGo Tajima
Go Tajima
YWYoriko Watanabe
Yoriko Watanabe
YHYuji Hotta
Yuji Hotta
YMYasuhiro Maeda
Yasuhiro Maeda